咪达那新是一种新型高效的选择性二苯基丁酰胺类毒蕈碱M1/M3受体阻断剂,主要应用于膀胱过度活动症所引起的尿急、尿频、尿禁等症状,在治疗尿失禁领域有广阔的应用前景。针对咪达那新的药理作用、药代动力学、临床应用及合成工艺等方面进行了归纳和比较,以期为其进一步研究及工业化生产提供参考。
Imidafenacin,4-(2-methyl-1H-imidazol-1-yl)-2,2-diphenylbutanamide,which is a novel antimuscarinic agent with high affinities for M3 and M1 muscarinic receptor subtypes and organ selectivity for the bladder, significantly developed for the treatment of overactive bladder(OAB) symptoms: urgency,urinary frequency, urinary incontinence. It has broad application prospects in the field of treatment of urinary incontinence. This paper is summarized and compared of pharmacological of action, pharmacokinetics clinical application and synthesis of imidafenacin, in order to further its research and industrial production to provide a reference.